Shamrock Asset Management’s AbbVie ABBV Stock Holding History

Shamrock Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$94K	Sell	1,236 -225	-15%	-$15.4K	0.07%	109
2019 Q2	$106K	Sell	1,461 -175	-11%	-$13.8K	0.08%	110
2019 Q1	$132K	Sell	1,636 -587	-26%	-$48K	0.1%	97
2018 Q4	$205K	Buy	2,223 +3	+0.1%	+$264	0.31%	70
2018 Q3	$210K	Sell	2,220 -436	-16%	-$41.3K	0.13%	98
2018 Q2	$246K	Sell	2,656 -92	-3%	-$8.98K	0.15%	98
2018 Q1	$292K	Sell	2,748 -130	-5%	-$14.3K	0.17%	94
2017 Q4	$278K	Buy	2,878 +101	+4%	+$9.52K	0.17%	86
2017 Q3	$247K	Buy	2,777 +476	+21%	+$36.2K	0.16%	84
2017 Q2	$167K	Sell	2,301 -506	-18%	-$34K	0.1%	102
2017 Q1	$183K	Buy	+2,807	New	+$176K	0.11%	103

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Shamrock Asset Management's ABBV Position: Q3 2019 in Review

Shamrock Asset Management reduced its AbbVie (ABBV) stake by 15% in Q3 2019, selling an estimated $15.4K and leaving 1,236 shares worth $94K. The position accounts for 0.07% of the portfolio, ranked #109.

Shamrock Asset Management first reported a position in ABBV in Q1 2017 and has held it in 11 quarters since. The position peaked at $292K in Q1 2018. 2,002 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

Shamrock Asset Management held 1,236 shares of AbbVie worth $94K as of Q3 2019.
Shamrock Asset Management sold 225 AbbVie shares in Q3 2019, an estimated $15.4K.
AbbVie made up 0.07% of Shamrock Asset Management's portfolio in Q3 2019, its #109 holding.
Shamrock Asset Management first reported a position in AbbVie in Q1 2017 and has held it in 11 quarters since.
Shamrock Asset Management's AbbVie position peaked at $292K in Q1 2018.
2,002 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Shamrock Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.